Data updated: Mar 10, 2026
CHLOROQUINE PHOSPHATE
CHLOROQUINE PHOSPHATE
Approved 1974-12-11
8
Indications
--
Phase 3 Trials
51
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1974-12-11
- Routes
- ORAL
- Dosage Forms
- TABLET
Companies
Teva WATSON LABS SUVEN PHARMS PUREPAC PHARM IPCA LABS LTD MD PHARM NATCO PHARMA LTD IMPAX LABS Hikma
Active Ingredient: CHLOROQUINE PHOSPHATE
Website: ↗
CHLOROQUINE PHOSPHATE Approval History
Loading approval history...
What CHLOROQUINE PHOSPHATE Treats
8 FDA approvalsOriginally approved for its first indication in 1974 . Covers 8 distinct patient populations.
- Other (8)
Other
(8 approvals)- • Approved indication (Dec 1974)
- • Approved indication (Jul 1975)
- • Approved indication (Jan 1982)
- • Approved indication (Dec 1982)
- • Approved indication (Aug 2003)
- • Approved indication (Dec 2009)
- • Approved indication (Jan 2011)
- • Approved indication (Sep 2021)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
CHLOROQUINE PHOSPHATE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.